Insider Trading History of Vivaldi Coelho Rogerio

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Vivaldi Coelho Rogerio since 2014. This trader's CIK number is 1610381. At the time of last reporting, Vivaldi Coelho Rogerio was the Officer of Viatris Inc. (stock ticker symbol VTRS). Also see all insider trading activities at Viatris Inc.

Note that in the past Vivaldi Coelho Rogerio also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Crinetics Pharmaceuticals, Inc. (CRNX) by Vivaldi Coelho Rogerio

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 CRNX 5,000 $110,300 0 $0 0 $0

Yearly summary of insider trading at Sigilon Therapeutics, Inc. (SGTX) by Vivaldi Coelho Rogerio

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 SGTX 0 $0 0 $0 5,528 $106,358

Yearly summary of insider trading at Minerva Neurosciences, Inc. (NERV) by Vivaldi Coelho Rogerio

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 NERV 41,667 $250,002 0 $0 0 $0

Yearly summary of insider trading at Viatris Inc (VTRS) by Vivaldi Coelho Rogerio

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 VTRS 0 $0 0 $0 21,691 $0

Yearly summary of insider trading at Spark Therapeutics, Inc. (ONCE) by Vivaldi Coelho Rogerio

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ONCE 0 $0 14,000 $652,120 14,000 $71,924
2015 ONCE 2,500 $57,500 65,000 $3,189,404 77,333 $498,997

Yearly summary of insider trading at Bioverativ Inc. (BIVV) by Vivaldi Coelho Rogerio

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 BIVV 0 $0 0 $0 7,114 $0


Insider trading activities at 6 companies by Vivaldi Coelho Rogerio:

1. Crinetics Pharmaceuticals, Inc. (CRNX)

2. Sigilon Therapeutics, Inc. (SGTX)

3. Minerva Neurosciences, Inc. (NERV)

4. Viatris Inc (VTRS)

5. Spark Therapeutics, Inc. (ONCE)

6. Bioverativ Inc. (BIVV)

Table 1. Insider trading of Crinetics Pharmaceuticals, Inc. (CRNX) by Vivaldi Coelho Rogerio

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-08 CRNX Buy 5,000 22.06 110,300

Table 2. Insider trading of Sigilon Therapeutics, Inc. (SGTX) by Vivaldi Coelho Rogerio

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-07-21 SGTX Option Ex 5,528 19.24 106,358

Table 3. Insider trading of Minerva Neurosciences, Inc. (NERV) by Vivaldi Coelho Rogerio

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-07-01 NERV Buy 41,667 6.00 250,002

Table 4. Insider trading of Viatris Inc (VTRS) by Vivaldi Coelho Rogerio

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-04 VTRS Option Ex 21,691 .00 0

Table 5. Insider trading of Spark Therapeutics, Inc. (ONCE) by Vivaldi Coelho Rogerio

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-07-15 ONCE Sale 7,000 53.14 371,980
2016-07-15 ONCE Option Ex 7,000 4.80 33,600
2016-04-20 ONCE Option Ex 5,800 5.47 31,754
2016-04-21 ONCE Option Ex 1,200 5.47 6,570
2016-04-20 ONCE Sale 5,800 40.02 232,116
2016-04-21 ONCE Sale 1,200 40.02 48,024
2015-10-13 ONCE Option Ex 37,333 7.50 279,997
2015-10-13 ONCE Sale 24,000 48.15 1,155,600
2015-10-07 ONCE Option Ex 40,000 5.47 219,000
2015-10-07 ONCE Sale 41,000 49.60 2,033,804
2015-02-04 ONCE Buy 2,500 23.00 57,500

Table 6. Insider trading of Bioverativ Inc. (BIVV) by Vivaldi Coelho Rogerio

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-02-14 BIVV Option Ex 7,114 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vivaldi Coelho Rogerio (Officer of Viatris Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.